Alaunos Therapeutics Inc.

TCRT | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.28

+$0.02 (+1.59%)

Sep 22, 2026, 1:15 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-4.18M	-4.68M	-35.14M	-37.73M	-78.75M	-79.98M
Depreciation & Amortization	7K	2K	2.32M	2.76M	2.6M	1.13M
Stock-Based Compensation	414K	435K	2.8M	3.53M	10.77M	6.83M
Other Working Capital	374K	-625K	-5.48M	-212K	-688K	16.29M
Other Non-Cash Items	413K	n/a	6.14M	1.34M	771K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	473K	-729K	-6.25M	870K	3.14M	15.01M
Operating Cash Flow	-2.87M	-4.97M	-30.14M	-29.23M	-61.47M	-57.01M
Capital Expenditures	-98K	n/a	-197K	-216K	-3.32M	-9.78M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	1.54M	23K	n/a	n/a
Investing Cash Flow	-98K	n/a	1.35M	-193K	-3.32M	-9.78M
Debt Repayment	n/a	n/a	-18.11M	-8.33M	25M	n/a
Common Stock Repurchased	n/a	n/a	n/a	-45K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-125K	21K	776K	442K
Financial Cash Flow	3.26M	n/a	-18.14M	6.37M	25.78M	102.12M
Net Cash Flow	294K	-4.97M	-46.93M	-23.06M	-39.02M	35.33M
Free Cash Flow	-2.97M	-4.97M	-30.34M	-29.45M	-64.79M	-66.79M
Adj. Free Cash Flow	-3.38M	-5.41M	-33.14M	-32.98M	-75.57M	-73.62M
Maintenance CapEx	-98K	n/a	-197K	n/a	-2.5M	-9.78M
Growth CapEx	n/a	n/a	n/a	-216K	-820.24K	n/a
Owner Earnings	-2.97M	-4.97M	-30.34M	-29.23M	-63.97M	-66.79M